Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SVA

Sernova (SVA)

Sernova Corp
Date:
Sort by:
 Showing the most relevant articles for your search:TSXV:SVA
DateTimeSourceHeadlineSymbolCompany
06/02/202211:00AMPR Newswire (Canada)Sernova Opens the MarketTSXV:SVASernova Corp
01/10/20229:48AMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - SVATSXV:SVASernova Corp
01/10/20229:46AMPR Newswire (Canada)IIROC Trading Resumption - SVATSXV:SVASernova Corp
01/10/20229:44AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - SVATSXV:SVASernova Corp
01/10/20229:41AMPR Newswire (Canada)IIROC Trading Halt - SVATSXV:SVASernova Corp
02/04/202110:01AMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - SVATSXV:SVASernova Corp
02/04/20219:58AMPR Newswire (Canada)IIROC Trading Resumption - SVATSXV:SVASernova Corp
02/04/20219:44AMPR Newswire (Canada)Sernova Upsizes Previously Announced Bought Deal Public Offering to C$20 MillionTSXV:SVASernova Corp
02/04/20219:38AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - SVATSXV:SVASernova Corp
02/04/20219:36AMPR Newswire (Canada)IIROC Trading Halt - SVATSXV:SVASernova Corp
02/03/20215:20PMPR Newswire (Canada)Sernova Corp. Announces C$10 Million Bought Deal Offering of UnitsTSXV:SVASernova Corp
01/15/20212:48PMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - SVATSXV:SVASernova Corp
01/15/20212:45PMPR Newswire (Canada)IIROC Trading Resumption - SVATSXV:SVASernova Corp
01/15/20212:30PMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - SVATSXV:SVASernova Corp
01/15/20212:27PMPR Newswire (Canada)IIROC Trading Halt - SVATSXV:SVASernova Corp
06/18/202012:58PMInvestorsHub NewsWirePURA SVA - Health Stocks Exhibit Healthy News, Robust Share HikesTSXV:SVASernova Corp
10/24/20197:30AMPR Newswire (Canada)Sernova Announces Biotech Veteran as New Chief Financial OfficerTSXV:SVASernova Corp
10/16/201912:55PMInvestorsHub NewsWireSernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in Phase I/II Clinical Trial for Type-ATSXV:SVASernova Corp
04/11/201912:14PMInvestorsHub NewsWireSernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical StudyTSXV:SVASernova Corp
07/05/201810:50AMInvestorsHub NewsWireSernova Initiates Patient Screening and Recruitment for its US Clinical Trial for DiabetesTSXV:SVASernova Corp
02/22/20188:35AMInvestorsHub NewsWireSernova's Cell Pouch Regenerative Medicine Clinical Trial for Type 1 Diabetes Supported with CGM SystemsTSXV:SVASernova Corp
12/11/20179:03AMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - SVATSXV:SVASernova Corp
12/11/20179:02AMPR Newswire (Canada)IIROC Trading Resumption - SVATSXV:SVASernova Corp
12/11/20177:56AMInvestorsHub NewsWireSernova Receives US FDA IND Allowance to Initiate a US Clinical Trial of its Cell Pouch for the Treatment of Type 1 DiabetesTSXV:SVASernova Corp
12/08/20172:20PMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - SVATSXV:SVASernova Corp
12/08/20172:19PMPR Newswire (Canada)IIROC Trading Halt - SVATSXV:SVASernova Corp
07/15/20146:00AMMarketwired CanadaSernova Agrees on Terms to Gain Access to Proprietary Stem Cell Technology For the Treatment of DiabetesTSXV:SVASernova Corp
06/24/20146:00AMMarketwiredSernova Team Participates at Key US Life Sciences Event: 2014 BIO International Convention, San DiegoTSXV:SVASernova Corp
06/24/20146:00AMMarketwired CanadaSernova Team Participates at Key US Life Sciences Event: 2014 BIO International Convention, San DiegoTSXV:SVASernova Corp
06/20/20146:00AMMarketwiredSernova's CEO Dr. Philip Toleikis Featured on BNNTSXV:SVASernova Corp
 Showing the most relevant articles for your search:TSXV:SVA